MustGrow Biologics Corp. (TSXV:MGRO)

Canada flag Canada · Delayed Price · Currency is CAD
1.010
-0.070 (-6.48%)
Mar 28, 2025, 3:59 PM EST
-14.41%
Market Cap 52.16M
Revenue (ttm) 4.99M
Net Income (ttm) -245.03K
Shares Out 51.64M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,162
Average Volume 10,800
Open 1.100
Previous Close 1.080
Day's Range 1.000 - 1.100
52-Week Range 0.620 - 2.530
Beta 1.40
RSI 33.11
Earnings Date Apr 24, 2025

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food ... [Read more]

Sector Materials
Founded 2014
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol MGRO
Full Company Profile

Financial Performance

In 2023, MustGrow Biologics's revenue was 4.71 million, an increase of 72630.36% compared to the previous year's 6,479. Losses were -676,940, -87.84% less than in 2022.

Financial Statements

News